• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Preferences for results delivery from exome sequencing/genome sequencing.外显子组测序/基因组测序结果交付的偏好
Genet Med. 2014 Jun;16(6):442-7. doi: 10.1038/gim.2013.170. Epub 2013 Dec 5.
2
Web Platform vs In-Person Genetic Counselor for Return of Carrier Results From Exome Sequencing: A Randomized Clinical Trial.网页平台与现场遗传咨询师在传递外显子组测序携带者结果方面的比较:一项随机临床试验。
JAMA Intern Med. 2018 Mar 1;178(3):338-346. doi: 10.1001/jamainternmed.2017.8049.
3
Future-oriented Emotions and Decisions to Receive Genomic Testing Results Among U.S. Adults of African Ancestry.美国非洲裔成年人的未来导向情绪与接受基因组检测结果的决策。
Ann Behav Med. 2023 Apr 22;57(5):418-423. doi: 10.1093/abm/kaac069.
4
Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing.林奇综合征患者对全外显子组测序结果反馈的看法及偏好
J Genet Couns. 2014 Aug;23(4):539-51. doi: 10.1007/s10897-014-9687-6. Epub 2014 Jan 22.
5
Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study.ClinSeq 研究参与者对获得个人全基因组测序结果的意愿。
Eur J Hum Genet. 2013 Mar;21(3):261-5. doi: 10.1038/ejhg.2012.179. Epub 2012 Aug 15.
6
When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.当分类模糊时:患者对临床全基因组测序结果类别的看法。
AJOB Empir Bioeth. 2017 Apr-Jun;8(2):82-88. doi: 10.1080/23294515.2017.1287786. Epub 2017 Jan 27.
7
Factors influencing NCGENES research participants' requests for non-medically actionable secondary findings.影响 NCGENES 研究参与者对非医学可操作性次要发现请求的因素。
Genet Med. 2019 May;21(5):1092-1099. doi: 10.1038/s41436-018-0294-z. Epub 2018 Sep 21.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Attitudes of non-African American focus group participants toward return of results from exome and whole genome sequencing.非非裔美国焦点小组参与者对全外显子组和全基因组测序结果反馈的态度。
Am J Med Genet A. 2014 Sep;164A(9):2153-60. doi: 10.1002/ajmg.a.36610. Epub 2014 May 20.
10
Actionable secondary findings following exome sequencing of 836 non-obstructive azoospermia cases and their value in patient management.对 836 例非梗阻性无精子症病例进行外显子组测序后的可操作的次要发现及其在患者管理中的价值。
Hum Reprod. 2022 Jun 30;37(7):1652-1663. doi: 10.1093/humrep/deac100.

引用本文的文献

1
How people undergoing genomic sequencing interpret and react to varied secondary findings with limited actionability.进行基因组测序的人如何解读并应对具有有限可操作性的各种次要发现。
Per Med. 2025 Apr;22(2):93-101. doi: 10.1080/17410541.2025.2476392. Epub 2025 Mar 18.
2
Research participant perceptions of personal utility in disclosure of individual research results from genomic analysis.研究参与者对基因组分析个体研究结果披露中个人效用的认知。
J Community Genet. 2024 Oct;15(5):529-538. doi: 10.1007/s12687-024-00734-7. Epub 2024 Sep 18.
3
Ethical, legal, and social implications (ELSI) and challenges in the design of a randomized controlled trial to test the online return of cancer genetic research results to U.S. Black women.伦理、法律和社会影响(ELSI)以及设计一项随机对照试验以测试美国黑人女性癌症遗传研究结果在线返还的挑战。
Contemp Clin Trials. 2023 Sep;132:107309. doi: 10.1016/j.cct.2023.107309. Epub 2023 Jul 27.
4
Demographic Characteristics Associated With Perceptions of Personal Utility in Genetic and Genomic Testing: A Systematic Review.与遗传和基因组检测中个人效用感知相关的人口统计学特征:系统评价。
JAMA Netw Open. 2023 May 1;6(5):e2310367. doi: 10.1001/jamanetworkopen.2023.10367.
5
Participant views on practical considerations for feedback of individual genetic research results: a case study from Botswana.参与者对个体基因研究结果反馈的实际考量的看法:来自博茨瓦纳的案例研究。
Glob Bioeth. 2023 Apr 12;34(1):1-14. doi: 10.1080/11287462.2023.2192329. eCollection 2023.
6
Great expectations: patients' preferences for clinically significant results from genomic sequencing.期望很高:患者对基因组测序产生临床显著结果的偏好。
Hum Genet. 2023 Apr;142(4):553-562. doi: 10.1007/s00439-023-02543-3. Epub 2023 Mar 21.
7
Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New Normal.使用大规模或全基因组测序进行基因组研究的结果回报:迈向新常态。
Annu Rev Genomics Hum Genet. 2023 Aug 25;24:393-414. doi: 10.1146/annurev-genom-101122-103209. Epub 2023 Mar 13.
8
Genotype first: Clinical genomics research through a reverse phenotyping approach.先基因型,后表型:通过反向表型方法进行临床基因组学研究。
Am J Hum Genet. 2023 Jan 5;110(1):3-12. doi: 10.1016/j.ajhg.2022.12.004.
9
Establishing the Medical Actionability of Genomic Variants.建立基因组变异的医学可操作性。
Annu Rev Genomics Hum Genet. 2022 Aug 31;23:173-192. doi: 10.1146/annurev-genom-111021-032401. Epub 2022 Apr 1.
10
Stakeholder Perspectives on Returning Nonactionable Apolipoprotein L1 (APOL1) Genetic Results to African American Research Participants.利益相关者对将无行动性载脂蛋白 L1(APOL1)遗传结果返还给非裔美国研究参与者的看法。
J Empir Res Hum Res Ethics. 2022 Feb-Apr;17(1-2):4-14. doi: 10.1177/15562646211063267. Epub 2021 Dec 6.

本文引用的文献

1
Practical, ethical and regulatory considerations for the evolving medical and research genomics landscape.不断演变的医学和研究基因组学领域的实践、伦理和监管考量
Appl Transl Genom. 2013 Feb 26;2:34-40. doi: 10.1016/j.atg.2013.02.001. eCollection 2013 Dec 1.
2
Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study.ClinSeq 研究参与者对获得个人全基因组测序结果的意愿。
Eur J Hum Genet. 2013 Mar;21(3):261-5. doi: 10.1038/ejhg.2012.179. Epub 2012 Aug 15.
3
Public preferences regarding the return of individual genetic research results: findings from a qualitative focus group study.公众对个体基因研究结果返还的偏好:一项定性焦点小组研究的结果。
Genet Med. 2012 Apr;14(4):451-7. doi: 10.1038/gim.2011.66. Epub 2012 Mar 8.
4
The beliefs, motivations, and expectations of parents who have enrolled their children in a genetic biorepository.参与遗传生物库的家长的信念、动机和期望。
Genet Med. 2012 Mar;14(3):330-7. doi: 10.1038/gim.2011.25. Epub 2012 Jan 26.
5
How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.新型分子诊断技术和生物标志物如何彻底改变基因检测和患者护理。
Expert Rev Mol Diagn. 2012 Jan;12(1):25-37. doi: 10.1586/erm.11.85.
6
Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.参与全基因组测序研究的动机:对转化基因组学研究的启示。
Eur J Hum Genet. 2011 Dec;19(12):1213-7. doi: 10.1038/ejhg.2011.123. Epub 2011 Jul 6.
7
Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time.在临床实践和公共卫生中应用全基因组测序:一次处理一个分类单元来应对挑战。
Genet Med. 2011 Jun;13(6):499-504. doi: 10.1097/GIM.0b013e318220aaba.
8
The advent of personal genome sequencing.个人基因组测序的出现。
Genet Med. 2011 Mar;13(3):188-90. doi: 10.1097/GIM.0b013e31820f16e6.
9
Preferences regarding genetic research results: comparing veterans and nonveterans responses.关于基因研究结果的偏好:比较退伍军人与非退伍军人的反应
Public Health Genomics. 2010;13(7-8):431-9. doi: 10.1159/000317099. Epub 2010 Sep 9.
10
Communication of biobanks' research results: what do (potential) participants want?生物银行研究结果的交流:(潜在)参与者想要什么?
Am J Med Genet A. 2010 Oct;152A(10):2482-92. doi: 10.1002/ajmg.a.33617.

外显子组测序/基因组测序结果交付的偏好

Preferences for results delivery from exome sequencing/genome sequencing.

作者信息

Wright Martha F, Lewis Katie L, Fisher Tyler C, Hooker Gillian W, Emanuel Toby E, Biesecker Leslie G, Biesecker Barbara B

机构信息

Genetic Disease & Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.

Social & Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Genet Med. 2014 Jun;16(6):442-7. doi: 10.1038/gim.2013.170. Epub 2013 Dec 5.

DOI:10.1038/gim.2013.170
PMID:24310310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4597884/
Abstract

PURPOSE

The aim of this study was to explore the implications of sequencing information and stated preferences for return of results among research participants.

METHODS

Six focus groups were held with 39 ClinSeq participants. The groups included participants who had received results, those who had not, those affected with cardiovascular disease, and healthy adults. Audio recordings of the sessions were transcribed and coded and analyzed for themes.

RESULTS

All participants expressed interest in receiving results that are medically actionable, nonactionable, carrier, and less so variants that cannot be interpreted. Most participants preferred to receive results in person, although several endorsed use of Internet-based resources that they could return to. Participants identified benefits for health management along with satisfying curiosity, making scientific contributions, and partnering in research. Value was seen in gaining control over health risks. Concerns were distress and/or fear that may result. Some participants were opposed to or ambivalent about learning certain types of results, particularly those having to do with diseases that were incurable or that might have implications for the health of their children.

CONCLUSION

There was relative enthusiasm about the value of learning sequencing information, yet it was tempered by concern about negative feeling responses and aversion to learning about incurable conditions.

摘要

目的

本研究旨在探讨测序信息的意义以及研究参与者对结果反馈的明确偏好。

方法

对39名临床测序项目参与者进行了6次焦点小组访谈。这些小组包括已收到结果的参与者、未收到结果的参与者、患有心血管疾病的参与者以及健康成年人。对访谈的音频记录进行了转录、编码和主题分析。

结果

所有参与者都表示有兴趣收到具有医学可操作性、不可操作性、携带者相关以及难以解释的变异等结果。大多数参与者倾向于亲自接收结果,不过也有一些人认可使用他们可以随时查阅的基于互联网的资源。参与者们指出了健康管理方面的益处,以及满足好奇心、做出科学贡献和参与研究合作等方面的好处。他们认为在控制健康风险方面有价值。担忧的是可能会产生困扰和/或恐惧。一些参与者反对或对了解某些类型的结果持矛盾态度,特别是那些与无法治愈的疾病或可能对其子女健康有影响的疾病有关的结果。

结论

对于了解测序信息的价值存在相对较高的热情,但对负面情绪反应的担忧以及对了解不治之症的反感使其有所缓和。